中国团队在美国展示心脏病介入治疗新成果

The Global Interventional Cardiovascular Therapy Conference 2025 opened on the 25th in San Francisco, California, USA. A Chinese research team presented the latest clinical data on medical devices for treating aortic regurgitation at the conference, showcasing the innovation, effectiveness, and safety of Chinese original devices. Academician of the Chinese Academy of Sciences and Professor Wang Jian'an from the Second Affiliated Hospital of Zhejiang University School of Medicine introduced the two-year clinical follow-up data of the "J-VALVE TF Transcatheter Aortic Valve System" for treating aortic regurgitation. This valve is accessed via a vascular approach, achieving a more minimally invasive treatment for aortic regurgitation through the synergistic innovation of device design and surgical techniques, resulting in shorter operation times and faster patient recovery